Monoclonal antibodies (mAbs) have pioneered discovery and development in biological science and medicine, playing an increasingly important role in research and drug discovery.
To meet this rising demand, researchers have developed alternative methods to accelerate antibody production – the generation of recombinant antibodies (rAbs), often in mammalian cell lines.
Since antibodies can possess a wide range of different characteristics, it is crucial that expression conditions are optimized for each individual rAb.
In this white paper, discover the steps to optimizing rAb expression, including how to:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
Email: privacy@technologynetworks.com
© 2020 Technology Networks. All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy